Back to all Programs

Register here

Related Materials

Past event

International Workshop on HIV & Pediatrics 2018

Debate: All children should be switched to dolutegravir-based ART regimens | Adeodata Kekitiinwa, MBChB, MMed

Debate: All children should be switched to dolutegravir-based ART regimens | Nandita Sugandhi

Early treatment and clinical outcomes – does early ART make a difference? | Louise Kuhn, PhD

Controllers: post-treatment vs elite controllers – what do we know? | Phillip Goulder, MA, FRCPCH, DPhil, FMedSc

HIV vaccines and broadly neutralizing monoclonal antibody - role in the cure agenda | Sandhya Vasan, MD

Clinical case presentations | Gareth Tudor Williams

Clinical case presentations | Moherndran Archary

Mobile technology for engaging children and youth in treatment and prevention | Lisa Hightow-Weidman MD, MPH

Debate:All infants should receive oral antiretroviral prophylaxis throughout breastfeeding

All infants should receive oral antiretroviral prophylaxis throughout breastfeeding | Amy Slogrove, MB ChB, MMed, PhD

All infants should receive oral antiretroviral prophylaxis throughout breastfeeding | Philippe van der Perre, MD, PhD

Malawi | Maria Kim, MD

Too small, too soon: antiretroviral prophylaxis and treatment in preterm and low birth weight infants | Mark Mirochnick MD

Challenges and successes in implementing rapid infant diagnostic testing | Patricia Fassinou, MD

Preventing HIV in young women in Africa – the importance of social protection | Lucie Cluver, PhD

The emerging pediatric population: youth with behaviorally-acquired HIV | Sarah Bernays, PhD

Current implementation | Shaffiq Essajee, MD